Home » Newsletters » BioWorld Science

BioWorld Science

May 15, 2020

View Archived Issues

Liver-specific pre-eclampsia treatment is maternal-specific

Novadip reports interim data from phase I/II bone non-union study of NVD-003

Advaxis reports positive preliminary data from ongoing phase I/II study of ADXS-503 in NSCLC

Abivax receives clearance to initiate phase IIb/III study of ABX-464 COVID-19 patients

FDA approves IND application for SMP-100 as treatment of IBS

Krystal Biotech announces positive interim data from phase I/II study of KB-105

Kaleido initiates developmental program of KB-109 in mild to moderate COVID-19

SHR-170008 immunotherapy demonstrates antitumor efficacy in vivo

Pharmacodynamic and safety data presented for emixustat

Researchers identify AMRC-835 for MBL-positive Gram-negative bacterial infections

Phase II/III data support potential of rAAV2-ND4 gene therapy in patients with LHON

Daiichi Sankyo, Sanford Burnham Prebys patent AP-TNAP inhibitors

Taiho Pharmaceutical discloses mutant GTPase KRAS inhibitors

New factor XIa and/or kallikrein B inhibitors identified at Merck & Co.

Bristol-Myers Squibb discovers Toll-like receptor antagonists

New kappa opioid receptor agonists synthesized at Nippon Chemiphar

Doubling down on edits keeps type 1 diabetes in check

EGFR identified as a target in some retinoblastoma tumors

MCo-PG1 shows good efficacy in Pseudomonas aeruginosa-driven sepsis model

European Commission approves Adcetris for previously untreated sALCL

Enzychem cleared to begin Korean phase II study with EC-18 to prevent ARDS in COVID-19

Danish study to evaluate iloprost in COVID-19 patients with ARDS

FDA accepts IND for iNKT therapy agenT-797 for cancer

Lyfaquin approved in India for hypovolemic shock

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...